| Financial Year |
March 31 2023 |
| Monetary Funds |
203,546,449.55 |
| Held-for-trading Financial Assets |
3,789,207.84 |
| Notes Receivable |
9,160,262.82 |
| Accounts Receivable |
315,889,337.12 |
| Advances to Suppliers |
44,651,479.65 |
| Other Receivables |
10,157,268.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
182,935,003.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,086,021.52 |
| Total Current Assets |
791,496,014.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,445,348.67 |
| Investment Properties |
4,745,756.58 |
| Fixed Assetes |
93,568,615.50 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,879,956.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
446,127.06 |
| Deferred Income Tax Assets |
19,591,427.47 |
| Other Non-Current Assets |
47,391,565.26 |
| Sub-Total of Non-Current Assets |
283,469,747.22 |
| Total Assets |
1,074,965,761.53 |
| Short-Term Loans |
47,240,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,487,145.17 |
| Accounts Payable |
137,375,357.79 |
| Accounts Received In Advance |
176,109.37 |
| Employee Compensation Payable |
2,159,867.26 |
| Taxes Payable |
1,258,225.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,786,861.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,542,481.40 |
| Other Current Liabilities |
18,644,771.74 |
| Sub-Total of Current Liabilities |
333,953,626.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,089,768.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,089,768.24 |
| Total Liabilities |
346,043,394.30 |
| Paid-In Capital(Or Share Stock) |
209,764,100.00 |
| Capital Surplus |
147,355,893.84 |
| Surplus Reserve |
51,678,296.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
302,913,616.75 |
| Minority Stockholder's Interest |
19,375,327.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
709,547,039.41 |
| Owner's Equity（Stockholder's Equity） |
728,922,367.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,074,965,761.53 |
